美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Onestream Inc

24.79

+0.02000.08%

成交量：125.30萬

成交額：3,118.24萬

市值：43.69億

市盈率：-14.03

高：25.22

開：24.87

低：24.40

收：24.77

資料載入中...

總覽公司新聞公告

AbbVie申請將Venclexta組合療法推進到CLL一線治療AbbVie files to move Venclexta combo into the CLL front line

Os Therapies Incorporated盤中異動大幅下跌6.01%

Os Therapies Incorporated盤中異動急速上漲5.03%報1.78美元

汽車汽配：6月乘用車零售銷量同比加速增長，國產品牌佔比達64.2%|興·研究

Os Therapies Incorporated盤中異動臨近收盤快速上漲5.37%報1.66美元

Os Therapies Incorporated盤中異動大幅下挫5.00%

Os Therapies Incorporated盤中異動急速跳水6.84%

Os Therapies Incorporated盤中異動股價大跌5.46%報1.73美元

海外消費週報：多項政策出臺支持創新藥高質量發展商保創新藥目錄有望於年內落地

申万宏源研究

Os Therapies Incorporated盤中異動早盤快速拉昇5.50%報2.02美元

“闖關”FDA，國產肺癌靶向藥物如何敲開美國大門？

21世纪经济报道

Os Therapies Incorporated盤中異動早盤大幅拉昇5.43%

Onestream, Inc.盤中異動下午盤股價大漲5.01%

Os Therapies Incorporated盤中異動急速拉昇8.14%報1.86美元

Onestream, Inc.盤中異動股價大跌5.00%

艾伯維Bcl-2抑制劑VERONA折戟

CPHI制药在线

艾伯維BCL-2抑制劑拓適應症失利，羅氏帕金森藥進Ⅲ期，FXIIa單抗在美上市

医药经济报

Os Therapies Incorporated盤中異動股價大跌5.79%報1.79美元

Os Therapies Incorporated盤中異動股價大跌5.16%報1.75美元

Os Therapies Incorporated盤中異動早盤大幅跳水5.61%報1.85美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":24.79,"timestamp":1753905600000,"preClose":24.77,"halted":0,"volume":1253035,"delay":0,"floatShares":69818472,"shares":176260091,"eps":-1.766751,"marketStatus":"盤前交易","change":0.02,"latestTime":"07-31 04:24:35 EDT","open":24.87,"high":25.22,"low":24.4,"amount":31182416.275885,"amplitude":0.033105,"askPrice":25.49,"askSize":20,"bidPrice":24.05,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.766751,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1753968600000},"marketStatusCode":1,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":24.79,"postHourTrading":{"tag":"盘后","latestPrice":24.78,"preClose":24.79,"latestTime":"18:56 EDT","volume":192807,"amount":4779683.74,"timestamp":1753916208007},"volumeRatio":1.3922113879958045,"impliedVol":0.7069,"impliedVolPercentile":0.7671},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","floatShares":69818472,"roa":"-35.83%","roe":"-108.78%","lyrEps":-1.232998,"volumeRatio":1.3922113879958045,"shares":176260091,"dividePrice":0,"high":25.22,"amplitude":0.033105,"preClose":24.77,"low":24.4,"week52Low":16.6942,"pbRate":"10.58","psRate":"8.48","week52High":35.39,"institutionHeld":0,"latestPrice":24.79,"committee":-0.333333,"eps":-1.766751,"divideRate":0,"volume":1253035,"delay":0,"ttmEps":-1.766751,"open":24.87,"prevYearClose":28.52,"prevWeekClose":25.01,"prevMonthClose":28.3,"prevQuarterClose":28.3,"fiveDayClose":25.24,"twentyDayClose":26.23,"sixtyDayClose":23.23,"earningDate":1754496000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555042530","title":"AbbVie申請將Venclexta組合療法推進到CLL一線治療AbbVie files to move Venclexta combo into the CLL front line","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042530","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555042530?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 21:18","pubTimestamp":1753881480,"startTime":"0","endTime":"0","summary":"AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia , in combination with an AstraZeneca drug.AbbVie已为其基于Venclexta疗法的方案申请批准，用于既往未经治疗的慢性淋巴细胞白血病患者，该方案与阿斯利康的一种药物联合使用。Calquence, meanwhile, is already approved for first-line CLL, but with a label that calls for treatment until disease progression, and approval based on the AMPLIFY data would allow patients to take a holiday from treatment, potentially reducing long-term side effects.Calquence 已经被批准用于一线 CLL 治疗，但其标签上要求持续治疗直到疾病进展，而基于 AMPLIFY 数据的批准将允许患者暂停治疗，这可能会减少长期副作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","LU1551013425.SGD","LU1037948897.HKD","LU1732800096.USD","ABBV","BK4566","BK4550","LU0256863902.USD","LU0234570918.USD","LU1037948541.HKD","IE0009355771.USD","LU1057294990.SGD","LU1983299246.USD","LU2089284900.SGD","LU2237443382.USD","LU0820561818.USD","LU0943347566.SGD","LU0912757837.SGD","LU1934455277.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0661504455.SGD","LU1093756168.USD","IE0002141913.USD","LU0738911758.USD","LU2347655156.SGD","AZ","IE0004445239.USD","LU0456855351.SGD","LU1934455194.USD","LU0985320562.USD","LU2129689431.USD","OS","SG9999015986.USD","LU1839511570.USD","IE00BJJMRZ35.SGD","LU1732799900.SGD","LU2237443465.HKD","BK4581","LU1989772840.SGD","LU1267930573.SGD","IE00BDGV0183.EUR","BK4533","LU2237443549.SGD","LU1003077747.HKD","LU1718418525.SGD","IE00B4R5TH58.HKD","LU1244550577.SGD","LU0158827948.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2554782697","title":"Os Therapies Incorporated盤中異動 大幅下跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782697?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 00:56","pubTimestamp":1753376179,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日00时56分，Os Therapies Incorporated股票出现异动，股价大幅跳水6.01%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Plus Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Liminatus Pharma, Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Purple Biotech Ltd较为活跃，换手率分别为662.59%、365.70%、163.77%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Psyence Biomedical Ltd.，振幅分别为55.13%、50.00%、47.44%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OSTX","OS"],"gpt_icon":0},{"id":"2553706257","title":"Os Therapies Incorporated盤中異動 急速上漲5.03%報1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553706257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553706257?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 01:02","pubTimestamp":1753203734,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日01时02分，Os Therapies Incorporated股票出现异动，股价快速拉升5.03%。截至发稿，该股报1.78美元/股，成交量22.2009万股，换手率0.65%，振幅3.08%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.59%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OSTX","BK4139","OS"],"gpt_icon":0},{"id":"2553273694","title":"汽車汽配：6月乘用車零售銷量同比加速增長，國產品牌佔比達64.2%|興·研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2553273694","media":"华兴证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553273694?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 16:30","pubTimestamp":1753086650,"startTime":"0","endTime":"0","summary":"6月动力电池装车量同比增长36.0%至58.2GWh，单车平均带电量为54.0KWh，环比增长4.2%。6月国内乘用车厂商的零售/批发/生产数量均创当月历史新高，国产品牌零售市场份额达到64.2%。6月乘用车和新能源车零售销量同比分别增长18.1%/29.8%。2025年上半年累计总体乘用车和新能源车零售销量分别为1,094.8万辆/545.8万辆，分别同比增长11.2%/34.1%。6月乘用车销量数据创当月历史新高，国产品牌销量占比达64.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","ADAG","BK4097","ANPDY","BK4139","ORR","02020","82020"],"gpt_icon":0},{"id":"2552317866","title":"Os Therapies Incorporated盤中異動 臨近收盤快速上漲5.37%報1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552317866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552317866?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 03:47","pubTimestamp":1752695271,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时47分，Os Therapies Incorporated股票出现异动，股价快速上涨5.37%。截至发稿，该股报1.66美元/股，成交量26.3095万股，换手率0.87%，振幅5.70%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.37%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717034752954531fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717034752954531fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OSTX","OS","BK4097"],"gpt_icon":0},{"id":"2551800841","title":"Os Therapies Incorporated盤中異動 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551800841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551800841?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 00:43","pubTimestamp":1752511431,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时43分，Os Therapies Incorporated股票出现波动，股价大幅下跌5.00%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2065.20%、1175.20%、705.77%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、206.36%、183.75%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500435295425610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500435295425610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4097","OS","BK4139"],"gpt_icon":0},{"id":"2550520979","title":"Os Therapies Incorporated盤中異動 急速跳水6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550520979?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 02:55","pubTimestamp":1752000957,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时55分，Os Therapies Incorporated股票出现异动，股价快速下挫6.84%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Zyversa Therapeutics, Inc.、湖岸生物、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为4137.58%、632.66%、349.51%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为146.75%、73.81%、70.96%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4097","OS","BK4139"],"gpt_icon":0},{"id":"2549558629","title":"Os Therapies Incorporated盤中異動 股價大跌5.46%報1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549558629?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 21:44","pubTimestamp":1751895870,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时44分，Os Therapies Incorporated股票出现波动，股价快速跳水5.46%。截至发稿，该股报1.73美元/股，成交量19.0751万股，换手率0.63%，振幅4.37%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2548836997","title":"海外消費週報：多項政策出臺支持創新藥高質量發展 商保創新藥目錄有望於年內落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2548836997","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548836997?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 00:00","pubTimestamp":1751558400,"startTime":"0","endTime":"0","summary":"此外，为适应多层次医疗保障体系发展需要，将增设商业健康保险创新药品目录，重点纳入创新程度高、临床价值大、患者获益显著且超出基本医保保障范围的创新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165124a72e766d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165124a72e766d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","01276","BK4139","09688","600276","HCM","RDC","00013","BK4548","BK4531","BK4097","BK4526","BK4588","ZLAB","OS","BK4585"],"gpt_icon":0},{"id":"2548038547","title":"Os Therapies Incorporated盤中異動 早盤快速拉昇5.50%報2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548038547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548038547?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 23:27","pubTimestamp":1751556471,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日23时27分，Os Therapies Incorporated股票出现异动，股价大幅拉升5.50%。截至发稿，该股报2.02美元/股，成交量738.564万股，换手率26.29%，振幅8.90%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.53%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070323275195356440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070323275195356440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4097","OS","BK4139"],"gpt_icon":0},{"id":"2548082944","title":"“闖關”FDA，國產肺癌靶向藥物如何敲開美國大門？","url":"https://stock-news.laohu8.com/highlight/detail?id=2548082944","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548082944?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 12:34","pubTimestamp":1751517293,"startTime":"0","endTime":"0","summary":"2025年初，迪哲医药研发的肺癌靶向药舒沃哲?（舒沃替尼片）向美国FDA递交新药上市申请并获得优先审评资格，这一消息在医药行业引起了广泛关注。就在7月3日，该药正式获得FDA批准上市，用于经治EGFRExon20ins晚期非小细胞肺癌（NSCLC）患者，成为中国首款独立研发在美获批的全球首创（First-in-Class）新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507033447331049.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507033447331049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4195","BK1141","BK1574","BK1576","BK4211","PFS","OS","06978","BK1583","BK1161","BK4097","03347"],"gpt_icon":0},{"id":"2547654018","title":"Os Therapies Incorporated盤中異動 早盤大幅拉昇5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547654018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547654018?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 21:47","pubTimestamp":1751291265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时47分，Os Therapies Incorporated股票出现波动，股价快速上涨5.43%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2370.48%、140.53%、78.46%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4097","BK4139","OS"],"gpt_icon":0},{"id":"2546756989","title":"Onestream, Inc.盤中異動 下午盤股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546756989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546756989?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 02:55","pubTimestamp":1750964127,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日02时55分，Onestream, Inc.股票出现异动，股价急速拉升5.01%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.72%。其相关个股中，Cyngn Inc.、Core Scientific Inc C/Wts 23/01/2027 、Webull Corporation C/Wts 10/04/2029 涨幅较大，Cyngn Inc.、Jet.AI、Urgent.Ly Inc.较为活跃，换手率分别为7237.79%、66.19%、47.49%，振幅较大的相关个股有Cyngn Inc.、Real Messenger Corp C/Wts 19/11/2029、Core Scientific Inc C/Wts 23/01/2027 ，振幅分别为575.25%、67.32%、66.72%。Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2546924612","title":"Os Therapies Incorporated盤中異動 急速拉昇8.14%報1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546924612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546924612?lang=zh_tw&edition=fundamental","pubTime":"2025-06-25 21:41","pubTimestamp":1750858902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时41分，Os Therapies Incorporated股票出现异动，股价急速上涨8.14%。截至发稿，该股报1.86美元/股，成交量2.6538万股，换手率0.09%，振幅2.04%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OSTX","OS"],"gpt_icon":0},{"id":"2545449870","title":"Onestream, Inc.盤中異動 股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545449870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545449870?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 00:33","pubTimestamp":1750696433,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时33分，Onestream, Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报26.39美元/股，成交量56.7111万股，换手率0.32%，振幅5.40%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.36%。其相关个股中，Currenc Group Inc.、Alpha Modus Holdings, Inc.、移动财经涨幅较大，Currenc Group Inc.、Wag!Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2544166696","title":"艾伯維Bcl-2抑制劑VERONA折戟","url":"https://stock-news.laohu8.com/highlight/detail?id=2544166696","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544166696?lang=zh_tw&edition=fundamental","pubTime":"2025-06-19 18:15","pubTimestamp":1750328104,"startTime":"0","endTime":"0","summary":"关注并星标CPHI制药在线Bcl-2抑制剂“水土不服”2025年6月16日，艾伯维宣布Bcl-2抑制剂维奈克拉联合阿扎胞苷一线治疗高危骨髓增生异常综合征的三期临床VERONA宣告失败。这种异质性导致不同患者对Bcl-2抑制剂的敏感性不同，使得药物难以对所有患者都产生理想疗效。Bcl-2抑制剂作用于白血病细胞的凋亡通路，但骨髓基质细胞的保护作用削弱了其疗效，使得白血病细胞难以被有效清除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211327993.USD","LU0234570918.USD","LU0320765646.SGD","LU2468319806.SGD","LU1244550221.USD","LU2087621335.USD","LU0158827948.USD","ABBV","LU0456855351.SGD","LU2089283258.USD","SG9999003800.SGD","CR","LU1267930573.SGD","LU2129689514.USD","LU1003077747.HKD","LU0689472784.USD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","LU1989772923.USD","HR","LU0203345920.USD","BK4585","IE00BVYPNV92.GBP","IE00B19Z3581.USD","LU1929549753.HKD","ORR","BK4161","TLS","LU1732800096.USD","LU0310799852.SGD","SG9999011175.SGD","SG9999015945.SGD","LU1496350171.SGD","BK4550","LU0417517546.SGD","LU1989771016.USD","IE00B19Z3B42.SGD","IE00BDGV0183.EUR","LU1934455863.HKD","BK4581","OS","LU0949170772.SGD","LU2129689431.USD","LU0965509283.SGD","LU0128525929.USD","LU1074936037.SGD","LU0965509101.SGD","LU1244550577.SGD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2544191987","title":"艾伯維BCL-2抑制劑拓適應症失利，羅氏帕金森藥進Ⅲ期，FXIIa單抗在美上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2544191987","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544191987?lang=zh_tw&edition=fundamental","pubTime":"2025-06-18 07:05","pubTimestamp":1750201511,"startTime":"0","endTime":"0","summary":"1.艾伯维/基因泰克BCL-2抑制剂拓适应症暂折戟6月16日，基因泰克与艾伯维宣布，BCL-2抑制剂Venclexta联合阿扎胞苷初治高危骨髓增生异常综合征患者的Ⅲ期VERONA研究临床试验未达总生存期这一主要终点。该药已在今年2月在欧盟获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618071318a70f3832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618071318a70f3832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0912757837.SGD","IE0002270589.USD","LU0234570918.USD","LU0985320562.USD","LU1244550221.USD","LU0203345920.USD","LU1023059063.AUD","LU2237443622.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU1551013425.SGD","LU0158827948.USD","LU1551013342.USD","LU1169589451.USD","LU2347655156.SGD","LU1929549753.HKD","IE0002141913.USD","IE00BGHQF631.EUR","LU0738911758.USD","LU1989771016.USD","OS","SG9999015986.USD","LU0456855351.SGD","IE00BLDYK493.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0205193047.USD","LU2237443549.SGD","LU2089284900.SGD","BK4533","LU1732799900.SGD","LU1934455863.HKD","LU2129689605.HKD","LU1989772923.USD","LU0256863902.USD","LU0553294199.USD","LU0820561818.USD","BK4585","LU2023251221.USD","ABBV","LU0820561909.HKD","LU0943347566.SGD","IE0004445239.USD","SG9999011175.SGD","LU1585245621.USD","HAE","BK4550","LU2237443382.USD","LU0965509101.SGD","LU0211327993.USD"],"gpt_icon":0},{"id":"2544373918","title":"Os Therapies Incorporated盤中異動 股價大跌5.79%報1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544373918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544373918?lang=zh_tw&edition=fundamental","pubTime":"2025-06-18 04:15","pubTimestamp":1750191335,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日04时15分，Os Therapies Incorporated股票出现波动，股价快速下挫5.79%。截至发稿，该股报1.79美元/股，成交量22.2987万股，换手率0.79%，振幅6.32%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为1.71%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS","BK4139","OSTX"],"gpt_icon":0},{"id":"2543263323","title":"Os Therapies Incorporated盤中異動 股價大跌5.16%報1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543263323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543263323?lang=zh_tw&edition=fundamental","pubTime":"2025-06-13 22:40","pubTimestamp":1749825650,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时40分，Os Therapies Incorporated股票出现异动，股价快速跳水5.16%。截至发稿，该股报1.75美元/股，成交量8.7732万股，换手率0.31%，振幅6.52%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.49%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS","BK4139","OSTX"],"gpt_icon":0},{"id":"2542384995","title":"Os Therapies Incorporated盤中異動 早盤大幅跳水5.61%報1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542384995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542384995?lang=zh_tw&edition=fundamental","pubTime":"2025-06-11 21:57","pubTimestamp":1749650258,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时57分，Os Therapies Incorporated股票出现波动，股价急速下跌5.61%。截至发稿，该股报1.85美元/股，成交量5.4093万股，换手率0.19%，振幅3.57%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.14%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","BK4139","OSTX"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OS\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"OS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.01,"defaultRemindTime":1754596800000,"name":null,"time":"盤後","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"OS","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-02-11","symbol":"OS","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-11-07","symbol":"OS","fiscalQuarterEnding":"2024/09","expectedEps":0,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2024-09-03","symbol":"OS","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5714,"hold":0.0952,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1753329600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OS","date":"2025-07-29","current":-18.588158,"percent":0.832653,"low":-1655.61542,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"high":-14.493656,"avg":-324.306428,"sd":560.783679,"marketCap":4373012857},"quantilePoints":[{"date":"2024-08-02","current":-402.058638,"twenty":-402.058638,"median":-402.058638,"eighty":-402.058638,"marketCap":4348264172},{"date":"2024-08-09","current":-394.529993,"twenty":-398.004752,"median":-394.602383,"eighty":-391.489578,"marketCap":4266841869},{"date":"2024-08-16","current":-420.156344,"twenty":-402.058638,"median":-395.977809,"eighty":-394.529993,"marketCap":4543990864},{"date":"2024-08-23","current":-418.563746,"twenty":-420.156344,"median":-400.248867,"eighty":-394.674774,"marketCap":4526766915},{"date":"2024-08-30","current":-439.701867,"twenty":-427.829772,"median":-415.668113,"eighty":-395.977809,"marketCap":4755375690},{"date":"2024-09-06","current":-1412.285699,"twenty":-434.093948,"median":-420.156344,"eighty":-395.977809,"marketCap":4652069092},{"date":"2024-09-13","current":-1421.532228,"twenty":-630.517125,"median":-426.381956,"eighty":-397.599363,"marketCap":4682527160},{"date":"2024-09-20","current":-1491.611188,"twenty":-1406.835113,"median":-428.55368,"eighty":-398.352228,"marketCap":4913367253},{"date":"2024-09-27","current":-1641.015636,"twenty":-1479.542034,"median":-435.672004,"eighty":-401.33473,"marketCap":5405505506},{"date":"2024-10-04","current":-1582.129844,"twenty":-1582.616503,"median":-445.348351,"eighty":-408.313205,"marketCap":5211535706},{"date":"2024-10-11","current":-1384.546111,"twenty":-1557.991535,"median":-1361.673117,"eighty":-414.50986,"marketCap":4560694889},{"date":"2024-10-18","current":-1422.505547,"twenty":-1506.405635,"median":-1387.466067,"eighty":-417.984619,"marketCap":4685733272},{"date":"2024-10-25","current":-1513.510863,"twenty":-1501.052381,"median":-1410.582391,"eighty":-419.837824,"marketCap":4985504782},{"date":"2024-10-31","current":-1488.204572,"twenty":-1545.825049,"median":-1419.58559,"eighty":-422.588676,"marketCap":4902145859},{"date":"2024-11-08","current":-29.444986,"twenty":-1544.267739,"median":-1421.532228,"eighty":-422.588676,"marketCap":5359016876},{"date":"2024-11-15","current":-29.547337,"twenty":-1525.190689,"median":-1414.232336,"eighty":-406.749563,"marketCap":5377644907},{"date":"2024-11-22","current":-27.361909,"twenty":-1504.167001,"median":-1405.472467,"eighty":-395.977809,"marketCap":4979894851},{"date":"2024-11-29","current":-26.339693,"twenty":-1496.769778,"median":-1384.546111,"eighty":-392.705744,"marketCap":4793850470},{"date":"2024-12-06","current":-28.33551,"twenty":-1493.655158,"median":-903.058146,"eighty":-29.829328,"marketCap":5157091209},{"date":"2024-12-13","current":-28.454992,"twenty":-1490.248542,"median":-439.701867,"eighty":-28.749622,"marketCap":5178836972},{"date":"2024-12-20","current":-27.223413,"twenty":-1484.895288,"median":-431.521704,"eighty":-28.258307,"marketCap":4954688343},{"date":"2024-12-27","current":-27.048786,"twenty":-1479.834029,"median":-428.191726,"eighty":-28.004145,"marketCap":4922906075},{"date":"2025-01-03","current":-25.973452,"twenty":-1479.444702,"median":-426.381956,"eighty":-27.732022,"marketCap":4727194212},{"date":"2025-01-10","current":-24.227183,"twenty":-1479.444702,"median":-422.183287,"eighty":-27.252823,"marketCap":4409371530},{"date":"2025-01-17","current":-26.460569,"twenty":-1468.54353,"median":-415.668113,"eighty":-26.869269,"marketCap":4815850013},{"date":"2025-01-24","current":-27.894348,"twenty":-1465.818237,"median":-402.058638,"eighty":-26.861301,"marketCap":5076799163},{"date":"2025-01-31","current":-27.407231,"twenty":-1462.314289,"median":-396.991281,"eighty":-26.925021,"marketCap":4988143362},{"date":"2025-02-07","current":-27.09474,"twenty":-1459.102337,"median":-394.674774,"eighty":-26.925021,"marketCap":4931269830},{"date":"2025-02-14","current":-19.646244,"twenty":-1457.642359,"median":-390.041762,"eighty":-26.782239,"marketCap":4247537655},{"date":"2025-02-21","current":-19.437413,"twenty":-1455.695721,"median":-30.305187,"eighty":-26.72172,"marketCap":4202388031},{"date":"2025-02-28","current":-18.385222,"twenty":-1452.094441,"median":-29.520901,"eighty":-26.562732,"marketCap":3974903390},{"date":"2025-03-07","current":-18.486889,"twenty":-1446.059864,"median":-28.777108,"eighty":-26.339693,"marketCap":3996883783},{"date":"2025-03-14","current":-16.449855,"twenty":-1440.122619,"median":-28.454992,"eighty":-26.179328,"marketCap":3556475076},{"date":"2025-03-21","current":-17.921046,"twenty":-1437.981318,"median":-28.198548,"eighty":-25.317223,"marketCap":3874548031},{"date":"2025-03-28","current":-18.76981,"twenty":-1430.38943,"median":-27.986257,"eighty":-24.094834,"marketCap":4058051659},{"date":"2025-04-04","current":-16.296269,"twenty":-1422.116219,"median":-27.889753,"eighty":-20.198845,"marketCap":3523269657},{"date":"2025-04-11","current":-15.87621,"twenty":-1419.974918,"median":-27.820821,"eighty":-19.520945,"marketCap":3432452458},{"date":"2025-04-17","current":-15.802935,"twenty":-1417.346957,"median":-27.682957,"eighty":-19.180725,"marketCap":3416610370},{"date":"2025-04-25","current":-17.317281,"twenty":-1415.400319,"median":-27.425612,"eighty":-18.846182,"marketCap":3744013527},{"date":"2025-05-02","current":-17.960471,"twenty":-1411.604376,"median":-27.370467,"eighty":-18.532156,"marketCap":3883071858},{"date":"2025-05-09","current":-18.233962,"twenty":-1408.19776,"median":-27.329108,"eighty":-18.405555,"marketCap":4289685457},{"date":"2025-05-16","current":-21.240398,"twenty":-1401.871187,"median":-27.223413,"eighty":-18.515128,"marketCap":4996973579},{"date":"2025-05-23","current":-21.307828,"twenty":-1386.882076,"median":-27.071763,"eighty":-18.645114,"marketCap":5012836988},{"date":"2025-05-30","current":-20.970679,"twenty":-1384.546111,"median":-26.979854,"eighty":-18.713226,"marketCap":4933519947},{"date":"2025-06-06","current":-21.779837,"twenty":-1366.053052,"median":-26.837395,"eighty":-18.714534,"marketCap":5123880845},{"date":"2025-06-13","current":-21.083062,"twenty":-1357.293182,"median":-26.745487,"eighty":-18.76981,"marketCap":4959958960},{"date":"2025-06-20","current":-21.397734,"twenty":-630.517125,"median":-26.722672,"eighty":-18.799724,"marketCap":5033988198},{"date":"2025-06-27","current":-20.715944,"twenty":-446.043303,"median":-26.635196,"eighty":-18.835877,"marketCap":4873591516},{"date":"2025-07-03","current":-19.974216,"twenty":-441.960461,"median":-26.551186,"eighty":-18.852455,"marketCap":4699094026},{"date":"2025-07-11","current":-19.329886,"twenty":-438.862005,"median":-26.400131,"eighty":-18.891318,"marketCap":4547510347},{"date":"2025-07-18","current":-18.603142,"twenty":-435.145985,"median":-26.322706,"eighty":-18.792246,"marketCap":4376538059},{"date":"2025-07-25","current":-18.767971,"twenty":-431.217662,"median":-26.184843,"eighty":-18.769074,"marketCap":4415315279},{"date":"2025-07-29","current":-18.588158,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"marketCap":4373012857}],"updateTime":1753950275695}}}